申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US20150191486A1
公开(公告)日:2015-07-09
Compounds represented by the formulas
wherein each symbol is as defined in the specification, and a prodrug thereof have a superior renin inhibitory activity, and are useful as agents for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension and the like.
根据本说明书中定义的每个符号,以及其前体化合物,所代表的化合物具有卓越的肾素抑制活性,并可作为预防或治疗高血压、高血压引起的各种器官损伤等疾病的药物。